Onitraz SB 50mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, histoplasmosis, blastomycosis, and onychomycosis. Onitraz SB 50mg is particularly effective against dermatophytes, yeasts, and molds. The capsule formulation facilitates oral administration and ensures adequate bioavailability. It is recommended to be taken with food to enhance absorption. Dosage and duration of therapy depend on the type and severity of infection, and treatment should be guided by a healthcare professional. Caution is advised in patients with hepatic impairment or congestive heart failure, as itraconazole may cause hepatotoxicity and negative inotropic effects. Potential drug interactions necessitate careful review of concomitant medications. Common adverse effects include gastrointestinal disturbances, headache, and rash. Regular monitoring of liver function tests is recommended during prolonged therapy. Onitraz SB 50mg Capsule offers an effective therapeutic option for fungal infections when used according to medical guidance.